Laxoberon (Sodium Picosulfate Monohydrate)

After oral intake, colonic bacteria convert sodium picosulfate monohydrate into an active metabolite that stimulates enteric nerves, increasing peristaltic activity and promoting secretion of water and electrolytes into the intestinal lumen, which together accelerate bowel transit and facilitate evacuation.

The appropriate dose of Laxoberon is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function and the specific bowel‑cleansing protocol required for the planned procedure.

Safety of sodium picosulfate monohydrate in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Laxoberon.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Laxoberon belongs to the stimulant‑laxative class, which acts by stimulating colonic nerves, unlike osmotic agents that draw water into the lumen. It generally produces a rapid bowel movement and is preferred for bowel‑preparation protocols, whereas osmotic laxatives may be used for chronic constipation with a gentler effect.

Laxoberon should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and heat to maintain its stability and efficacy.

Laxoberon is taken orally, usually as a single dose or divided doses as directed by a healthcare professional. The tablet (or oral preparation) is swallowed with water, and the patient should follow any specific timing instructions related to the upcoming diagnostic or surgical procedure.

The most serious risks include severe dehydration, significant electrolyte disturbances such as hyponatremia or hypokalemia, and rare allergic reactions that may manifest as rash, itching, or angioedema. Prompt medical attention is required if any of these serious symptoms occur.

Laxoberon should be avoided in individuals with known hypersensitivity to sodium picosulfate, acute intestinal obstruction, severe renal impairment, or in patients for whom rapid bowel evacuation is contraindicated. A physician should evaluate suitability before prescribing.